All In MedTech

Device Trial Radar · NCT00963742

Lenstec Softec HD Posterior Chamber Intraocular Lens Clinical Investigational Protocol

Lenstec Softec HD Posterior Chamber Intraocular Lens (PCIOL) Clinical Investigational Protocol

Last checked: Nov 20, 2026Latest source record: Mar 18, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

390

Actual

Start

Dec 2006

Primary completion

Jul 2009

Study completion Apr 2010

Sponsor

Lead sponsor
Lenstec IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Aug 21, 2009

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 21 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objectives of this multi-center clinical investigation are to determine the safety and effectiveness of the Lenstec Softec HD Posterior Chamber intraocular lens (IOL) following one year of post-operative assessment.

Conditions

  • Cataract

Interventions

  • Lenstec Softec HD IOL implantationDevice

    surgical removal of cataract and implantation of Softec HD PCIOL

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Distance Best Corrected Visual AcuityTime frame: 1 year

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.